Other languages Sol-Gel Technologies Ltd. Börse Stuttgart

Equities

4SG

IL0011417206

Delayed Börse Stuttgart Other stock markets 04:30:06 2024-07-01 EDT			5-day change	1st Jan Change
0.795 ^EUR	+1.92%		-5.45%	-27.78%

05-28	Sol-Gel Technologies Gets Noncompliance Notice From Nasdaq	MT
05-28	Sol-Gel Technologies Ltd. Announces Resignation of Gilad Mamlok as Chief Financial Officer, Effective September 21, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sol-Gel Technologies Gets Noncompliance Notice From Nasdaq	05-28
Sol-Gel Technologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-20
Sol-Gel Technologies Ltd. and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize Twyneo® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel	05-16
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-13
Sol-Gel Technologies Ltd. Elects Yuval Yanai as External Director	02-29
Sol-Gel Technologies Ltd. Screens First Patient for SGT-610 Phase 3 Study	11-30
Sol-Gel Technologies Ltd. Announces Resignation of Shmuel Ben Zvi from Board	11-20
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Sol-Gel Technologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Sol-Gel Technologies Ltd. Appoints Sharon Kochan to the Board of Directors	23-07-27
Sol-Gel Technologies, Searchlight Pharma Sign Licensing Deals for 2 Dermatology Drugs	23-06-06
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO and EPSOLAY in Canada	23-06-06
Sol-Gel Technologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-10
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-10
Sol-Gel Technologies Launches $22.8 Million Registered Direct, Private Placement Offerings; Shares Drop Pre-Bell	23-01-27
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21
Sol-Gel Technologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04
Sol-Gel Technologies Secures FDA Approval for EPSOLAY	22-04-25
Sol-Gel Technologies Announces FDA Approval of EPSOLAY	22-04-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sol-Gel Technologies Ltd. Börse Stuttgart

Equities

4SG

IL0011417206

Other languages

Filters